Skip to main content

Day: September 16, 2024

Ferrellgas Honors its Drivers During National Truck Driver Appreciation Week

LIBERTY, Mo., Sept. 16, 2024 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR), is honoring our Drivers during National Truck Driver Appreciation Week. Without them, we wouldn’t be able to do what we do – deliver easy propane service to millions of families. This year, Ferrellgas’ theme for National Truck Driver Appreciation Week is Miles of Gratitude. Whether our Drivers are hauling propane across the country as part of Ferrell North America (FNA), delivering it to someone’s home or business as part of Ferrellgas operations, or refilling a display of Blue Rhino grilling cylinders at a store, every mile counts. Our propane gets to its final destination safely and efficiently because of them, and we’re proud to have them as a key part of our nationwide supply network. “At the end of the day, we deliver propane. We couldn’t...

Continue reading

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today that the United States District Court for the District of New Jersey (District Court) has found that the interference by United Therapeutics Corporation (United Therapeutics) with the launch of generic Treprostinil Injection caused losses in excess of $137M. Treprostinil Injection is manufactured by Sandoz Inc. (Sandoz) and was launched as the first-to-file, fully-substitutable generic treprostinil for parenteral administration in March 2019. Liquidia PAH, LLC (formerly known as RareGen), a wholly owned subsidiary of Liquidia (Liquidia PAH), partnered with Sandoz in August 2018 on an exclusive basis to market...

Continue reading

Healthy Choice Wellness Corp. Announces Listing on NYSE American, Pricing of Initial Public Offering and Completion of Spin-Off from Healthier Choices Management Corp.

HOLLYWOOD, FL, Sept. 16, 2024 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives, announced today the pricing of its initial public offering of 400,000 shares of the Company’s Class A common stock, par value $0.001 per share, at an offering price of $10.00 per share, for gross proceeds of approximately $4.0 million, before deducting underwriting discounts and offering expenses (the “Offering”). In addition, HCWC has granted the underwriters a 45-day option to purchase up to an additional 60,000 shares of Class A common stock to cover over-allotments at the initial public offering price, less the underwriting discount. The Company also announced today that...

Continue reading

High Income Securities Fund Announces Special Meeting

MILWAUKEE, Sept. 16, 2024 (GLOBE NEWSWIRE) — High Income Securities Fund (the “Fund”) (NYSE: PCF) announced today that a special meeting of shareholders will be held on Friday, October 18, 2024 at 10:30 am at the office of Bulldog Investors, LLP, 250 Pehle Avenue, Suite 708, Saddle Brook, NJ 07663 to consider, among other things, (1) the Fund entering into an investment advisory agreement with Bulldog Investors, LLP, and (2) changes to the Fund’s investment strategies and fundamental policies in order to expand the types of investments the Fund can make and to increase the Fund’s ability to pursue attractive investment opportunities. Shortly after the special meeting is held, the Fund’s Board of Trustees intends to authorize a tender offer by the Fund to purchase at least (a) 90% of the number of shares issued in the rights offering...

Continue reading

Estonian Financial Intelligence Unit’s fine to LHV Pank cancelled by court order

The Harju County Court has decided to fully cancel the EUR 300,000 fine decision, that the Financial Intelligence Unit made in the beginning of May, and to end the proceedings against AS LHV Pank due to the absence of signs of misdemeanor. The Financial Intelligence Unit has 15 days to appeal the Harju County Court’s order. LHV Group is the largest domestic financial group and capital provider in Estonia. The LHV Group’s key subsidiaries are LHV Pank, LHV Varahaldus, LHV Kindlustus, and LHV Bank Limited. The Group employs over 1,100 people. As at the end of July, LHV’s banking services are being used by 437,000 clients, the pension funds managed by LHV have 118,000 active clients, and LHV Kindlustus protects a total of 167,000 clients. LHV Bank Limited, a subsidiary of the Group, holds a banking licence in the United Kingdom and provides...

Continue reading

Flagship Communities Real Estate Investment Trust Announces September 2024 Cash Distribution

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (the “REIT”) (TSX:MHC.U; MHC.UN) announced today a cash distribution of US$0.0492 per REIT unit for the month of September 2024, representing US$0.59 per REIT unit on an annual basis. Payment will be made on or about October 15, 2024, to unitholders of record as of the close of business on September 30, 2024. Distributions paid to Canadian unitholders (and other non-U.S. unitholders) generally will be subject to U.S. withholding tax. Unitholders should consult their own tax advisors for advice with respect to the tax consequences of receiving a distribution from the REIT in their own circumstances. About Flagship Communities Real Estate Investment Trust Flagship...

Continue reading

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

GAITHERSBURG, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today it has entered into agreements with two additional site locations to administer the Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma. Four of the planned six trial sites are now prepared to enroll patients in the clinical trial, including the UVA Cancer Center, John Theurer Cancer Center at Hackensack University Medical Center, Allegheny Health Network (AHN) Cancer Institute, and Miami Cancer Institute, part of Baptist Health South Florida. “I am pleased to report yet another key milestone in the...

Continue reading

ESGL and STMicroelectronics Singapore Create World’s First Sustainable Bricks Made from Semiconductor Waste

SINGAPORE, Sept. 16, 2024 (GLOBE NEWSWIRE) — ESGL Holdings Limited (NASDAQ: ESGL), a leading carbon neutral, innovative enviro-tech company regenerating industrial waste into circular products, and STMicroelectronics (ST), a global semiconductor leader serving customers across the spectrum of electronics applications, marked a significant milestone in their collaborative journey towards sustainability by creating the world’s first sustainable brick forged with NEWSPAR, regenerated from Hydrofluoric wastewater sludge and Hydrofluoric Acid. Revolutionary Technology and Circular Innovation Leveraging its cutting-edge technology, ESGL has successfully regenerated ST’s wastewater hydrofluoric sludges and Hydrofluoric Acid into an innovative circular material known as NEWSPAR. NEWSPAR is a proprietary material developed by ESGL, specifically...

Continue reading

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss WHITE BEAR LAKE, Minnesota, Sept. 16, 2024 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces it has been awarded another patent from the US Patent & Trademark Office for its fully implanted devices. On September 3rd, the Company was issued Patent No. 12,081,061, “Recharge System for Implantable Battery,” which relates to predicting a cumulative thermal dose associated with charging an implantable rechargeable energy storage device to a fully charged state and adjusting the amount of current provided to the device during charging. In other words, this can be used to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.